questionsmedicales.fr
Phénomènes génétiques
Structures génétiques
Vecteurs génétiques
Vecteurs génétiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Vecteurs génétiques : Questions médicales les plus fréquentes",
"headline": "Vecteurs génétiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Vecteurs génétiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-04",
"dateModified": "2025-03-30",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Vecteurs génétiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Structures génétiques",
"url": "https://questionsmedicales.fr/mesh/D040342",
"about": {
"@type": "MedicalCondition",
"name": "Structures génétiques",
"code": {
"@type": "MedicalCode",
"code": "D040342",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels",
"alternateName": "Chromosomes, Artificial",
"url": "https://questionsmedicales.fr/mesh/D022201",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels",
"code": {
"@type": "MedicalCode",
"code": "D022201",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de bactérie",
"alternateName": "Chromosomes, Artificial, Bacterial",
"url": "https://questionsmedicales.fr/mesh/D022202",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de bactérie",
"code": {
"@type": "MedicalCode",
"code": "D022202",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.170"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de mammifère",
"alternateName": "Chromosomes, Artificial, Mammalian",
"url": "https://questionsmedicales.fr/mesh/D022221",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de mammifère",
"code": {
"@type": "MedicalCode",
"code": "D022221",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels humains",
"alternateName": "Chromosomes, Artificial, Human",
"url": "https://questionsmedicales.fr/mesh/D022222",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels humains",
"code": {
"@type": "MedicalCode",
"code": "D022222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190.117"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels humains",
"alternateName": "Chromosomes, Artificial, Human",
"url": "https://questionsmedicales.fr/mesh/D022222",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels humains",
"code": {
"@type": "MedicalCode",
"code": "D022222",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.190.117"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosome artificiel du bactériophage P1",
"alternateName": "Chromosomes, Artificial, P1 Bacteriophage",
"url": "https://questionsmedicales.fr/mesh/D027042",
"about": {
"@type": "MedicalCondition",
"name": "Chromosome artificiel du bactériophage P1",
"code": {
"@type": "MedicalCode",
"code": "D027042",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.195"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Chromosomes artificiels de levure",
"alternateName": "Chromosomes, Artificial, Yeast",
"url": "https://questionsmedicales.fr/mesh/D018244",
"about": {
"@type": "MedicalCondition",
"name": "Chromosomes artificiels de levure",
"code": {
"@type": "MedicalCode",
"code": "D018244",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.337.249.200"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Vecteurs génétiques",
"alternateName": "Genetic Vectors",
"code": {
"@type": "MedicalCode",
"code": "D005822",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Joel O Odero",
"url": "https://questionsmedicales.fr/author/Joel%20O%20Odero",
"affiliation": {
"@type": "Organization",
"name": "International Centre of Insect Physiology and Ecology (icipe), P.O. Box 30772-00100, Nairobi, Kenya."
}
},
{
"@type": "Person",
"name": "John M Marshall",
"url": "https://questionsmedicales.fr/author/John%20M%20Marshall",
"affiliation": {
"@type": "Organization",
"name": "5Division of Epidemiology and Biostatistics, School of Public Health, University of California, Berkeley, California."
}
},
{
"@type": "Person",
"name": "Mauro Toledo Marrelli",
"url": "https://questionsmedicales.fr/author/Mauro%20Toledo%20Marrelli",
"affiliation": {
"@type": "Organization",
"name": "Institute of Tropical Medicine, University of São Paulo, São Paulo 05403-000, Brazil."
}
},
{
"@type": "Person",
"name": "Elizabeth Hemming-Schroeder",
"url": "https://questionsmedicales.fr/author/Elizabeth%20Hemming-Schroeder",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology and Evolutionary Biology and Program in Public Health, University of California, Irvine, CA, 92617, USA."
}
},
{
"@type": "Person",
"name": "Daibin Zhong",
"url": "https://questionsmedicales.fr/author/Daibin%20Zhong",
"affiliation": {
"@type": "Organization",
"name": "Department of Ecology and Evolutionary Biology and Program in Public Health, University of California, Irvine, CA, 92617, USA."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "SARS-CoV-2 rapid antigen screening of asymptomatic employees: a pilot project.",
"datePublished": "2022-09-12",
"url": "https://questionsmedicales.fr/article/36097245",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.17269/s41997-022-00691-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Health Disparities Investigator Development through a Team-Science Pilot Projects Program.",
"datePublished": "2023-03-30",
"url": "https://questionsmedicales.fr/article/37047951",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph20075336"
}
},
{
"@type": "ScholarlyArticle",
"name": "Global pen pal education intervention among student pharmacists: A pilot project.",
"datePublished": "2022-09-22",
"url": "https://questionsmedicales.fr/article/36153244",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cptl.2022.09.020"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Disposable Diaper Collection Project in Langa, Cape Town, South Africa: A Pilot Study.",
"datePublished": "2024-09-27",
"url": "https://questionsmedicales.fr/article/39457265",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/ijerph21101292"
}
},
{
"@type": "ScholarlyArticle",
"name": "Changing the Playing Field: A Prehospital Blood Product Pilot Project in Rural North Georgia.",
"datePublished": "2023-02-16",
"url": "https://questionsmedicales.fr/article/36798046",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1177/00031348231157833"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Vecteurs génétiques",
"item": "https://questionsmedicales.fr/mesh/D005822"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Vecteurs génétiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Vecteurs génétiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-09",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Vecteurs génétiques",
"description": "Comment identifier un vecteur génétique ?\nQuels tests pour évaluer l'efficacité d'un vecteur ?\nQuels marqueurs sont utilisés pour les vecteurs ?\nComment détecter des vecteurs viraux ?\nQuels sont les critères de sécurité des vecteurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Pilot+Projects&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Vecteurs génétiques",
"description": "Quels symptômes d'une thérapie génique ?\nY a-t-il des effets secondaires des vecteurs ?\nComment les vecteurs affectent-ils les cellules ?\nQuels signes d'infection par vecteur viral ?\nLes vecteurs peuvent-ils causer des tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Pilot+Projects&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Vecteurs génétiques",
"description": "Comment prévenir les effets indésirables des vecteurs ?\nY a-t-il des protocoles de sécurité pour les vecteurs ?\nComment minimiser les risques d'infection ?\nLes vaccins utilisent-ils des vecteurs ?\nComment évaluer la sécurité des vecteurs ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Pilot+Projects&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Vecteurs génétiques",
"description": "Comment les vecteurs sont-ils utilisés en thérapie ?\nQuels types de vecteurs sont courants ?\nComment choisir un vecteur pour un traitement ?\nQuels vecteurs pour les maladies héréditaires ?\nLes vecteurs peuvent-ils être administrés par voie orale ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Pilot+Projects&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Vecteurs génétiques",
"description": "Quelles complications peuvent survenir avec les vecteurs ?\nLes vecteurs peuvent-ils causer des maladies auto-immunes ?\nComment gérer les complications des vecteurs ?\nLes vecteurs peuvent-ils provoquer des allergies ?\nQuels sont les risques de transmission de maladies ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Pilot+Projects&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Vecteurs génétiques",
"description": "Quels facteurs augmentent les risques liés aux vecteurs ?\nLes patients immunodéprimés sont-ils à risque ?\nComment l'âge influence-t-il les risques ?\nLes antécédents d'allergies sont-ils un facteur ?\nQuels vecteurs sont plus risqués ?",
"url": "https://questionsmedicales.fr/mesh/D005822?mesh_terms=Pilot+Projects&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier un vecteur génétique ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs génétiques sont identifiés par leur capacité à transporter des gènes et à les exprimer."
}
},
{
"@type": "Question",
"name": "Quels tests pour évaluer l'efficacité d'un vecteur ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de transfection et d'expression génique sont utilisés pour évaluer l'efficacité."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour les vecteurs ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des marqueurs fluorescents ou de résistance aux antibiotiques sont souvent utilisés."
}
},
{
"@type": "Question",
"name": "Comment détecter des vecteurs viraux ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques comme la PCR et le séquençage sont utilisées pour détecter des vecteurs viraux."
}
},
{
"@type": "Question",
"name": "Quels sont les critères de sécurité des vecteurs ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs doivent être non pathogènes et ne pas induire de réponse immunitaire excessive."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une thérapie génique ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent inclure des réactions immunitaires, des inflammations ou des douleurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des effets secondaires des vecteurs ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des effets secondaires comme des nausées ou des réactions allergiques peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment les vecteurs affectent-ils les cellules ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs peuvent modifier l'expression génique, entraînant des changements fonctionnels."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection par vecteur viral ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent fièvre, fatigue, et symptômes respiratoires selon le vecteur."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils causer des tumeurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe un risque théorique que certains vecteurs induisent des tumeurs par insertion génique."
}
},
{
"@type": "Question",
"name": "Comment prévenir les effets indésirables des vecteurs ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une évaluation rigoureuse et des tests précliniques peuvent aider à prévenir les effets indésirables."
}
},
{
"@type": "Question",
"name": "Y a-t-il des protocoles de sécurité pour les vecteurs ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des protocoles de sécurité stricts sont établis pour l'utilisation des vecteurs en recherche."
}
},
{
"@type": "Question",
"name": "Comment minimiser les risques d'infection ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des vecteurs non pathogènes et suivre des pratiques de laboratoire sécurisées."
}
},
{
"@type": "Question",
"name": "Les vaccins utilisent-ils des vecteurs ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains vaccins utilisent des vecteurs pour introduire des antigènes dans l'organisme."
}
},
{
"@type": "Question",
"name": "Comment évaluer la sécurité des vecteurs ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des études cliniques et des évaluations de risques sont nécessaires pour évaluer la sécurité."
}
},
{
"@type": "Question",
"name": "Comment les vecteurs sont-ils utilisés en thérapie ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont utilisés pour délivrer des gènes thérapeutiques dans des cellules cibles."
}
},
{
"@type": "Question",
"name": "Quels types de vecteurs sont courants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux, plasmidiques et lipidiques sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Comment choisir un vecteur pour un traitement ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix dépend de la cible cellulaire, de la taille du gène et de la sécurité."
}
},
{
"@type": "Question",
"name": "Quels vecteurs pour les maladies héréditaires ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux comme les lentivirus sont souvent utilisés pour les maladies héréditaires."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils être administrés par voie orale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains vecteurs peuvent être administrés oralement, mais l'efficacité est souvent limitée."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les vecteurs ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des réactions immunitaires, des infections et des tumeurs."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils causer des maladies auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il existe un risque potentiel que certains vecteurs déclenchent des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications des vecteurs ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut le suivi médical, des traitements symptomatiques et des ajustements de dosage."
}
},
{
"@type": "Question",
"name": "Les vecteurs peuvent-ils provoquer des allergies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des réactions allergiques peuvent survenir en réponse aux vecteurs utilisés."
}
},
{
"@type": "Question",
"name": "Quels sont les risques de transmission de maladies ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il y a un risque de transmission de maladies si des vecteurs viraux sont mal utilisés."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent les risques liés aux vecteurs ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antécédents médicaux, l'âge et le type de vecteur utilisé peuvent augmenter les risques."
}
},
{
"@type": "Question",
"name": "Les patients immunodéprimés sont-ils à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les patients immunodéprimés peuvent avoir un risque accru d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les risques ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé peut affecter la réponse immunitaire et augmenter les risques d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Les antécédents d'allergies sont-ils un facteur ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'allergies peuvent augmenter le risque de réactions aux vecteurs."
}
},
{
"@type": "Question",
"name": "Quels vecteurs sont plus risqués ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vecteurs viraux, en particulier ceux dérivés de virus pathogènes, présentent plus de risques."
}
}
]
}
]
}
└─
Chromosomes artificiels
Chromosomes, Artificial
D022201
-
G05.360.337.249
└─└─
Chromosomes artificiels de bactérie
Chromosomes, Artificial, Bacterial
D022202
-
G05.360.337.249.170
└─└─
Chromosomes artificiels de mammifère
Chromosomes, Artificial, Mammalian
D022221
-
G05.360.337.249.190
└─└─
Chromosome artificiel du bactériophage P1
Chromosomes, Artificial, P1 Bacteriophage
D027042
-
G05.360.337.249.195
└─└─
Chromosomes artificiels de levure
Chromosomes, Artificial, Yeast
D018244
-
G05.360.337.249.200
└─└─└─
Chromosomes artificiels humains
Chromosomes, Artificial, Human
D022222
-
G05.360.337.249.190.117
Rapid antigen screening can be effective in identifying infectious individuals in occupational settings to reduce transmission and outbreaks. We report results from a pilot project at the Greater Toro...
An employee screening program was piloted between March 8 and May 28, 2021, to implement rapid antigen testing for asymptomatic employees. Recruitment targeted enrolment of 400 employees and yielded p...
A total of 5117 tests were performed on 717 individuals over 12 weeks; 5091 tests were negative (99.5%), and 22 individuals tested positive (3.1% positivity rate). One hundred twenty-four (17%) comple...
This pilot program identified 22 (3.1%) potentially infectious employees. Onsite testing was feasible and highly accepted by this group of employees who completed the survey. Education resulted in rea...
Profound health disparities are widespread among Native Hawaiians, other Pacific Islanders, and Filipinos in Hawai'i. Efforts to reduce and eliminate health disparities are limited by a shortage of in...
Global health, a practice that prioritizes improving health and achieving health equity for all people worldwide, is a priority for pharmacists, schools, and pharmacy colleges. Several initiatives aim...
This mixed-method study included assigned engagement within a required or elective didactic course, followed by a post-experience survey. Each student was pre-assigned a pen pal from a cohort of pharm...
In total, 184 students completed the learning experience, and across both sites, 63 students completed the post-experience survey. The students' impressions of the PPP varied by site, yet most partici...
In developing countries, there is currently no established waste management plan that includes resource recovery from used disposable diapers (DDs) apart from incineration and landfilling. In low-inco...
In Georgia, the paramedic's scope of practice prohibited the initiation of blood products. Due to the rural landscape in Georgia, one region's Regional Trauma Advisory Committee (RTAC) advocated expan...
Approval was obtained from the state medical directors and the Office of EMS and Trauma. The project team addressed product selection, equipment, prehospital service selection, education, policies and...
The pilot project began in spring of 2020, and as of January 2023, there have been 100 field initiations and no adverse effects, demonstrating the safety of paramedics to initiate blood products in th...
Future physicians are insufficiently prepared for the topic of transgender identity during their studies. Relevant courses during undergraduate medical education are heterogeneous and not widely estab...
During summer semester 2021 (SS21), the knowledge level on transgender identity of 134 medical students in their fifth clinical semester was evaluated (phase 1). In addition, knowledge gain on gender ...
The students in SS21 did not feel sufficiently educated in the topic of transgender identity through their studies, but rated the relevance of the topic for their later profession as high. Learning ga...
One 90-minutes seminar led to a significant learning gain regarding the topic of transgender identity. Community-supported teaching is a promising way to impart knowledge in a qualified manner: Medica...
To trial methods for a future longitudinal study to: a) assess how the redevelopment of a large social housing estate affects the health of tenants; and b) act on health needs identified throughout th...
Participants recruited from the tenant population completed (online or face-to-face) a health questionnaire covering self-reported health status and behaviours, housing conditions, sense of community,...
A total of 24 tenants were recruited for the pilot study against a target sample size of 50. The health questionnaire and referral process worked as expected, with no issues reported....
This pilot study successfully trialled methods for: a) assessing tenants' health; and b) referring those identified as being likely to have unmet health service needs to a community-based link worker,...
We developed a paediatric haemodialysis trigger tool (pHTT) for application per haemodialysis (HD) session in children receiving intermittent in-centre HD and systematically monitored adverse events....
Single-centre quality improvement study performed over two 8-week cycles. Data collected prospectively using a 'per-dialysis session' pHTT tool including 54 triggers across six domains, adapted from a...
There were 241 triggers over 182 dialysis sessions, with 139 triggers in 91 HD sessions for 15 children, age range 28-205 months, over an 8-week period (first cycle) and 102 triggers in 91 HD sessions...
This pilot study demonstrates potential benefits of a bedside tool to monitor adverse events during haemodialysis in children. Thus, following interventions informed by the pHTT, the harm rate per ses...
American Indian Alaska Native (AIAN) youth have disproportionately higher rates of commercial tobacco product use compared to other racial and ethnic groups in the U.S. These rates underscore a need f...
The "Virtual Semester for Medical Research Aachen" (vSEMERA) is an international, interdisciplinary, virtual education program developed for health profession students. The first edition (2021) was ho...
vSEMERA was built on a virtual learning platform, the "vSEMERA-Campus", designed to foster students' learning process and social interactions. Maximum flexibility was offered through synchronous and a...
The program received a rating of 4.38 out of 5 stars. While it met most expectations (4.29 out of 5), participants were unable to attend as many courses as intended (2.81 out of 5), mainly due to sche...
vSEMERA represents a promising example of an online international learning and exchange program using pedagogical and technological elements of virtual collaboration and teaching. In addition to advan...